{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T19:01:58Z","timestamp":1780426918338,"version":"3.54.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,26]]},"abstract":"<jats:p>\n                    Hepatitis B virus-associated intrahepatic cholangiocarcinoma (HBV-ICC) exhibits distinct clinicopathological characteristics, and the role of lymph-node dissection (LND) in its management remains contentious. This study aims to evaluate the clinical value of LND in HBV-ICC. Clinicopathological data of 76 HBV-ICC patients treated at Pingxiang People\u2019s Hospital between 2015 and 2020 were analyzed. The cohort comprised 41 patients who underwent LND (LND[+] group) and 35 patients who did not (LND[\u2212] group). Clinicopathological characteristics, perioperative outcomes, and survival were subjected to statistical analysis. The cohort had 1-, 2-, and 5- year overall survival (OS) rates of 85.5%, 27.6%, and 13.2%. The LND(+) group had significantly higher postoperative complications than the LND(\u2212) group (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). OS and postoperative recurrence rates did not significantly differ between the 2 groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.71 and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.44). Multivariate analysis showed that independent risk factors for poor prognosis after ICC resection included resection margin\u2005&lt;\u20051cm (HR\u2005=\u20053.97 [2.11\u20137.48],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), poor tumor differentiation (HR\u2005=\u20050.43 [0.19\u20130.95],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), microvascular invasion (HR\u2005=\u20051.92 [0.98\u20133.78],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05), and nonanatomic hepatectomy (HR\u2005=\u20052.07 [1.13\u20133.81],\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Resection margin, tumor differentiation, microvascular invasion, and anatomic hepatectomy were identified as independent prognostic factors in HBV-ICC. LND did not improve patient outcomes while potentially increasing complication risks, thus not recommended.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044576","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:01:20Z","timestamp":1759248080000},"page":"e44576","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The clinical value of lymph-node dissection in hepatitis B virus-associated intrahepatic cholangiocarcinoma"],"prefix":"10.1097","volume":"104","author":[{"given":"Fu-Ping","family":"Zhong","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Pingxiang People\u2019s Hospital, Pingxiang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Qin","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Pingxiang People\u2019s Hospital, Pingxiang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Pingxiang People\u2019s Hospital, Pingxiang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Pingxiang People\u2019s Hospital, Pingxiang, Jiangxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-8083","authenticated-orcid":false,"given":"Ye","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Pingxiang Second People\u2019s Hospital, Pingxiang, Jiangxi Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260602","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma.","volume":"72","author":"Kelley","year":"2020","journal-title":"J Hepatol"},{"key":"R2-20260602","doi-asserted-by":"crossref","first-page":"100378","DOI":"10.1016\/j.esmoop.2021.100378","article-title":"How I treat biliary tract cancer.","volume":"7","author":"Lamarca","year":"2022","journal-title":"ESMO Open"},{"key":"R3-20260602","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14737140.2022.1999809","article-title":"Surgical management of intrahepatic cholangiocarcinoma.","volume":"22","author":"Hewitt","year":"2022","journal-title":"Expert Rev Anticancer Ther"},{"key":"R4-20260602","doi-asserted-by":"crossref","first-page":"52","DOI":"10.21037\/cco.2018.07.03","article-title":"Intrahepatic cholangiocarcinoma: the AJCC\/UICC 8th edition updates.","volume":"7","author":"Lee","year":"2018","journal-title":"Chin Clin Oncol"},{"key":"R5-20260602","doi-asserted-by":"crossref","first-page":"942","DOI":"10.21037\/jgo.2017.11.06","article-title":"Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States.","volume":"9","author":"Altman","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"R6-20260602","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.hpb.2024.03.1163","article-title":"Is routine lymph node dissection recommended for liver resection of intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.","volume":"26","author":"Ishii","year":"2024","journal-title":"HPB (Oxford)"},{"key":"R7-20260602","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.4251\/wjgo.v15.i11.2017","article-title":"Role of routine lymph node dissection alongside resection of intrahepatic cholangiocarcinoma: systematic review and meta-analysis.","volume":"15","author":"Atif","year":"2023","journal-title":"World J Gastrointest Oncol"},{"key":"R8-20260602","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.hpb.2018.12.011","article-title":"Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.","volume":"21","author":"Zhou","year":"2019","journal-title":"HPB (Oxford)"},{"key":"R9-20260602","doi-asserted-by":"crossref","first-page":"19726","DOI":"10.1038\/s41598-023-47108-6","article-title":"A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees.","volume":"13","author":"Huang","year":"2023","journal-title":"Sci Rep"},{"key":"R10-20260602","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13027-022-00457-9","article-title":"Hepatitis B and C virus infections and the risk of biliary tract cancers: a meta-analysis of observational studies.","volume":"17","author":"Wang","year":"2022","journal-title":"Infect Agent Cancer"},{"key":"R11-20260602","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s12072-023-10556-3","article-title":"Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.","volume":"17","author":"Song","year":"2023","journal-title":"Hepatol Int"},{"key":"R12-20260602","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/jmri.28855","article-title":"MRI for Hepatitis B-Associated Intrahepatic cholangiocarcinoma: a multicenter comparative study.","volume":"59","author":"Sheng","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"R13-20260602","doi-asserted-by":"crossref","first-page":"17292","DOI":"10.18632\/oncotarget.14079","article-title":"Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.","volume":"8","author":"Jeong","year":"2017","journal-title":"Oncotarget"},{"key":"R14-20260602","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40001-022-00741-9","article-title":"The focus clinical research in intrahepatic cholangiocarcinoma.","volume":"27","author":"Song","year":"2022","journal-title":"Eur J Med Res"},{"key":"R15-20260602","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/brv.12457","article-title":"Comprehensive review of Hepatitis B virus-associated hepatocellular carcinoma research through text mining and big data analytics.","volume":"94","author":"Lee","year":"2019","journal-title":"Biol Rev Camb Philos Soc"},{"key":"R16-20260602","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s12072-022-10419-3","article-title":"Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma.","volume":"16","author":"Zhao","year":"2022","journal-title":"Hepatol Int"},{"key":"R17-20260602","doi-asserted-by":"crossref","first-page":"106003","DOI":"10.1016\/j.isci.2023.106003","article-title":"Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma.","volume":"26","author":"Shen","year":"2023","journal-title":"iScience"},{"key":"R18-20260602","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology.","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"R19-20260602","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement.","volume":"17","author":"Weber","year":"2015","journal-title":"HPB (Oxford)"},{"key":"R20-20260602","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/bjs.10827","article-title":"Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma.","volume":"105","author":"Zhang","year":"2018","journal-title":"Br J Surg"},{"key":"R21-20260602","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/liv.14415","article-title":"Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients.","volume":"40","author":"Li","year":"2020","journal-title":"Liver Int"},{"key":"R22-20260602","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/labmed\/lmx064","article-title":"Serum levels of IL-6, IL-8, TNF-alpha, and TGF-beta in chronic HBV-infected patients: effect of depression and anxiety.","volume":"49","author":"Bahramabadi","year":"2017","journal-title":"Lab. Med"},{"key":"R23-20260602","article-title":"Tumor microenvironment heterogeneity and progression mechanisms in intrahepatic cholangiocarcinoma: a study based on single-cell and spatial transcriptomic sequencing [published online ahead of print June 9, 2025].","author":"Li","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"R24-20260602","doi-asserted-by":"crossref","first-page":"S1093","DOI":"10.1245\/s10434-015-4768-9","article-title":"Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery.","volume":"22","author":"Kato","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R25-20260602","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study.","volume":"37","author":"Edeline","year":"2019","journal-title":"J Clin Oncol"},{"key":"R26-20260602","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"R27-20260602","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2017.11.015","article-title":"Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.","volume":"68","author":"Lei","year":"2018","journal-title":"J Hepatol"},{"key":"R28-20260602","doi-asserted-by":"crossref","first-page":"20230079","DOI":"10.1259\/bjr.20230079","article-title":"Transarterial chemoembolization plus lenvatinib with or without a PD-1 inhibitor for advanced and metastatic intrahepatic cholangiocarcinoma: a retrospective real-world study.","volume":"96","author":"Ning","year":"2023","journal-title":"Br J Radiol"},{"key":"R29-20260602","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.7150\/ijbs.21149","article-title":"Transarterial chemoembolization: a favorable postoperative management to improve prognosis of Hepatitis B virus-associated intrahepatic cholangiocarcinoma after surgical resection.","volume":"13","author":"Jeong","year":"2017","journal-title":"Int J Biol Sci"},{"key":"R30-20260602","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1245\/s10434-019-07260-8","article-title":"Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma.","volume":"26","author":"Si","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R31-20260602","doi-asserted-by":"crossref","first-page":"44521","DOI":"10.18632\/oncotarget.17815","article-title":"Actual over 10-year survival after liver resection for patients with intrahepatic cholangiocarcinoma.","volume":"8","author":"Si","year":"2017","journal-title":"Oncotarget"},{"key":"R32-20260602","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamasurg.2013.5168","article-title":"A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.","volume":"149","author":"Hyder","year":"2014","journal-title":"JAMA Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:01:35Z","timestamp":1780423295000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":32,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044576","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"2025-06-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}